Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma | Zendy

MaryAnn El Sharouni | Zendy; Karina Aivazian | Zendy; Arjen J. Witkamp | Zendy; V. Sigurdsson | Zendy; Carla H. van Gils | Zendy; Richard A. Scolyer | Zendy; John F. Thompson | Zendy; P. J. van Diest | Zendy; Serigne Lo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma

Author(s) -

MaryAnn El Sharouni,

Karina Aivazian,

Arjen J. Witkamp,

V. Sigurdsson,

Carla H. van Gils,

Richard A. Scolyer,

John F. Thompson,

P. J. van Diest,

Serigne Lo

Publication year - 2020

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2020.5032

Subject(s) - medicine , proportional hazards model , hazard ratio , cohort , melanoma , cancer registry , stage (stratigraphy) , breslow thickness , population , superficial spreading melanoma , cohort study , cancer , oncology , confidence interval , breast cancer , paleontology , sentinel lymph node , environmental health , cancer research , biology

Although regression is commonly observed in cutaneous melanoma, it is uncertain whether it is associated with patient prognosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research